Proton-beam grids with 3 mm beam elements produce dose distributions in water for which the grid pattern is preserved down to large depths. PBGT could be carried out at proton therapy centers, equipped with spot-scanning possibilities, using existing tools. However, smaller beams than those currently available could be advantageous for biological reasons. With PBGT, it is also possible to create a more uniform target dose than what has been possible to produce with photon-beam grids. We anticipate that PBGT could be a useful technique to reduce both short-and longterm side effects after radiotherapy.
Material and Methods: Three steps have been added to our current EPID dosimetry back-projection model to account for the presence of the MRI scanner: i) subtraction of scatter from the MRI to the EPID, ii) correction for the MRI attenuation, iii) compensation for changes in the beam spectrum. The calibration of the algorithm needs a set of commissioning data (from EPID and ionization chamber, both with and without the MRI) to determine the parameters for the back-projection method. An aluminum block of 12 cm thickness at 15 cm distance from the EPID was used to approximate the effects of the MRI scanner. Measurements were performed using a 6MV photon beam of a conventional SL20i linear accelerator (Elekta AB, Stockholm, Sweden) at 0° gantry. 58 IMRT fields of 11 plans (H&N, lung, prostate and rectum) were delivered to a 20 cm polystyrene slab phantom and portal images were acquired with the aluminum plate in place. For independent comparison with our conventional method the same fields were delivered without the aluminum plate. The EPID images were converted to dose, corrected for the presence of the aluminum plate, back-projected into the phantom and compared to the planned dose distribution using a 2-D gamma evaluation (3%, 3 mm).
Results:
The γ_mean averaged over the 58 IMRT fields was 0.39±0.11, the γ_1% was 1.05±0.30 and the %_γ≤1 was 95.7±5.3. The dose difference at the isocenter was -0.7±2.2 cGy. These results are in close agreement with the performance of our algorithm for the conventional linac setup (Table 1) .
Conclusion:
Our EPID dosimetry back projection algorithm was successfully adapted for the presence of an attenuating medium between phantom (or patient) and EPID. Experiments using a 12 cm aluminum plate (approximating the MR-linac geometry) showed excellent agreement between planned and EPID reconstructed dose distributions. This result is an essential step towards an accurate, independent, and potentially fast field-by-field IMRT portal dosimetry based verification tool for the MR-linac. Part of this research was sponsored by Elekta AB.
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Hyperthermia treatment planning in the pelvis using thermophysical fluid modelling of the bladder G. Schooneveldt Purpose or Objective: Hyperthermia is a (neo)adjuvant treatment modality that increases the effectiveness of radiotherapy or chemotherapy by heating the tumour area to 41-43 °C. Loco-regional hyperthermia is delivered using phased array systems with individually controlled antennae. Hyperthermia treatment planning is necessary to determine the phase and amplitude settings for the individual antennae that result in the optimal temperature distribution. Current treatment planning systems are accurate for solid tissues but ignore the specific properties of the urinary bladder and its contents, which limits their accuracy in the pelvic region. This may have clinical implications for such treatment sites as the rectum, the cervix uteri, and the bladder itself.
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The aim of this study is to incorporate a physically correct description of the bladder properties in treatment planning, most notably the presence of convection and the absence of perfusion, and to assess the differences with the conventional model.
Material and Methods:
We created a convective thermophysical fluid model based on the Boussinesq approximation to the Navier-Stokes equations; this means we assumed all parameters to be temperature independent except for the mass density in the gravitational term. We implemented this using the (finite element) OpenFOAM toolkit, and coupled it to our (finite difference) in-house developed treatment planning system, based on Pennes' bioheat equation. A CT scan was obtained from a bladder cancer patient and an experienced clinician delineated the bladder as part of the standard clinical work-flow. Based on this input, we first performed the treatment planning the conventional way with a muscle-like solid bladder, and calculated the optimal phase and amplitude settings for all four antennae. Next, we redid the temperature calculation with the expanded treatment planning system with a fluid-filled bladder, using the same settings. We subsequently calculated the differences between the two temperature distributions.
Results:
The temperature in the bladder with realistic fluid modelling is much higher than without, as the absence of perfusion in the bladder filling leads to a much lower heat removal. The maximum temperature difference was 3.6 °C. Clinically relevant tissue temperature differences of more than 0.5 °C extended to 1.75 cm around the bladder. The temperature distribution according to the convective model and the difference with the solid only model are shown in Figure 1 . The difference reflects the homogenizing effect of convection within the bladder and the nett heat transport in the upward direction.
Conclusion:
The addition of the new convective model to the hyperthermia treatment planning system leads to clinically highly relevant temperature changes. Explicit modelling of fluids is particularly important when the bladder or its direct surroundings are part of the treatment target area. Purpose or Objective: There have been concerns that the quality of highly conformal dose distributions, delivered under active MRI guidance, may be degraded by the influence of the magnetic field on secondary electrons. This planning study quantifies this effect for stereotactic body radiotherapy (SBRT) of lung tumors, conducted either with or without real-time multileaf collimator (MLC) tumor tracking.
Material and Methods:
The Elekta Monaco treatment planning software, research version 5.09.07, was used to design treatment plans on the peak-exhale 4DCT phase of nine patients undergoing lung SBRT. The software features a machine model of the Atlantic MR-linac system and allows dose calculation and plan optimization under consideration of a magnetic field. For each patient, we prepared four different 9-beam stepand-shoot IMRT plans: two for conventional, non-tracked treatment and two for delivery with real-time MLC tumor tracking, each delivered either with or without a 1.5T magnetic field oriented in the superior-inferior patient direction. For the conventional delivery, the internal target volume was defined as the union of the gross tumour volumes (GTV), delineated on each 4DCT phase. For the tracked delivery, the moving target volume was defined as union of all GTVs, each corrected for the center-of-volume shift thus accounting for target deformations. Dose was prescribed according to the RTOG 1021 guideline. Delivery of the respective plans was simulated to all 4DCT phases and the doses were then deformably accumulated onto the peakexhale phase. In order to evaluate the effect of the magnetic field and realtime tumor tracking, several dose-volume metrics and the integral deposited energy in the body were compared. Statistical significance of the differences was evaluated using a two-sided paired t-test after verifying normal distribution of them, while correcting for multiple testing for the four primary endpoints.
Results:
The table presents the differences in the investigated dose-volume metrics due to either the presence of a magnetic field or real-time MLC tumor tracking. Most prominently, the magnetic field caused an increase in dose to the skin and a decrease of dose to the GTV (see figure) . While statistically significant, the magnitude of these differences is small. In all 36 simulated dose deliveries, the dose prescription to the target was fulfilled and there were only minor violations of normal tissue constraints. Real-time MLC tumor tracking was able to maintain dose coverage of the GTV while reducing the integral deposited energy. This results in a decrease in dose to the skin and normal lung tissue, both with and without a magnetic field.
